Another research in lung and pancreatic cancer patient-derived xenograft models further indicated that METTL13 depletion markedly inhibited KRAS-driven pancreatic tumorigenesis (Liu et al. 2019b). This evidence concerns the gene METTL13 and pancreatic neoplasm.